Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA accepts Dupixent (dupilumab) for children with moderate-to-severe atopic dermatitis

February 10, 2022
Business Services

The FDA has accepted the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) for children aged six months to five …

News

FDA investigate possible increased risk of death with lymphoma medicine

February 9, 2022
Research and Development

The FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). The administration is continuing …

News

SaNOtize breakthrough treatment 99% effective against COVID-19

February 9, 2022
Research and Development

SaNOtize and Glenmark Pharmaceuticals Limited have announced successful results of their Phase III clinical trials, as well as the approval …

News

Despite persistent need, J&J halts COVID-19 vaccine output

February 9, 2022
Research and Development

Johnson & Johnson has temporarily suspended production at a key plant manufacturing the COVID-19 vaccine. The easily administered vaccine is …

News

NHS waiting-list backlog will take years to clear, ministers say

February 9, 2022

Ministers say that the waiting list for hospital treatment will not start falling for two years, in spite of unveiling …

News

Thermo Fisher Scientific partners with Medidata Acorn AI for clinical research advancement

February 8, 2022
Manufacturing and Production

Thermo Fisher Scientific has announced a multiyear partnership with medidata Acorn AI, a Dassault Systemes company leading the digital transformation …

News

Thousands with advanced prostate cancer to benefit from drug approval

February 8, 2022
Manufacturing and Production

Astellas has announced that the SMC has accepted the use of XTANDIâ„¢ (enzalutamide) to treat patients with metastatic hormone-sensitive prostate …

News

SMC approves diroximel fumarate as multiple sclerosis treatment

February 8, 2022
Manufacturing and Production

The SMC has approved VUMERITY (diroximel fumarate), a next-generation oral fumarate for the treatment of adults living with relapsing-remitting multiple …

News

First immunotherapy to treat advanced endometrial cancer on the NHS via Cancer Drugs Fund

February 8, 2022
Manufacturing and Production

GSK has shared that NICE is to issue a final appraisal determination (FAD) recommending the use of JEMPERLI®▼ (dostarlimab) via …

News
fejiomfxwaeana8

First gene therapy for rare genetic neurodegenerative disorder in children

February 7, 2022
Sales and Marketing

NICE has published a draft highly specialised technologies guidance, recommending gene therapy atidarsagene autotemcel for some children with the rare, …

News

NICE approves new treatment for chronic heart failure

February 7, 2022
Sales and Marketing

Empagliflozin (Jardiance®) has received a positive NICE recommendation for the treatment of chronic heart failure. NICE has announced that empagliflozin …

News

NICE recommends new combination for untreated advanced kidney cancer

February 4, 2022
Medical Communications

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has issued a Final …

News

NICE issues FAD for Forxiga in adults with chronic kidney disease

February 4, 2022
Medical Communications

NICE has issued a Final Appraisal Document (FAD) recommending Forxiga (dapagliflozin) within its marketing authorisation for the treatment of adults …

News

Emmes supports new collaboration to advance COVID-19 research for children

February 4, 2022
Medical Communications

Clinical research organisation, Emmes, announced its role as a Data Coordinating Center on a team whose work has accelerated paediatric …

News

University of Oxford: new HIV variant discovered

February 4, 2022

A new and highly HIV variant with higher virulence, and more damaging health impacts, has been discovered in the Netherlands.In …

News

FDA orphan drug designation for treatment of rare blood cancer

February 3, 2022
Business Services

The FDA has granted orphan drug designation (ODD) to tamibarotene for the treatment of myelodysplastic syndrome (MDS). The Office of …

News

Vaginal HRT tablets to become available over the counter

February 3, 2022
Business Services

Vaginal oestrogen tablets, a type of hormone replacement therapy (HRT) – could become available in chemists soon, depending on the …

News

Illumina to advance precision medicine approach for late-stage cancer patients

February 3, 2022
Business Services

Illumina announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University in France, to assess the clinical value …

News

CMA fines firms £35m for illegal arrangement

February 3, 2022
Business Services

The Competition and Markets Authority (CMA) has fined firms over £35 million for an illegal arrangement in the supply of …

News

Novavax submits EUA to FDA for COVID-19 vaccine candidate

February 2, 2022
Research and Development

Maryland-based Novavax has announced it is submitting an EUA request to the FDA, for its COVID-19 vaccine candidate.Novavax initially planned …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026